A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...
Patients undergoing a donor stem-cell transplant for leukemia or other blood-related cancer require months of specialized ...
It's important, now more than ever, for Blacks to talk to their doctors about the possibility of participating in clinical ...
Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery ...